Initially, immunohistochemical analysis revealed high expression of CCDC34 in bladder tumors compared with normal urothelium, and Western blot confirmed that CCDC34 was expressed at higher level in human bladder cancer tissues compared with their paraneoplastic bladder tissues. The gene discussed is CCDC34; the disease is urinary bladder carcinoma.